A new drug – crizotinib (Xalkori) – may be more beneficial than chemotherapy for some lung cancer patients.
US scientists have developed an improved method of collecting and growing rogue cancer cells from blood samples.
Routine tests that look for multiple, specific genetic changes in patients’ lung tumours could help doctors select targeted treatments.
Revolutionary clinical trial aims to advance lung cancer treatment thanks to Cancer Research UK and Pharma partnership
Cancer Research UK is partnering with pharmaceutical companies to create a pioneering clinical trial for patients with advanced lung cancer